Log In
BCIQ
Print this Print this
 

MT-3724

  Manage Alerts
Collapse Summary General Information
Company Molecular Templates Inc.
DescriptionEngineered toxin body (ETB) against CD20
Molecular Target CD20
Mechanism of Action 
Therapeutic ModalityActive immunotherapy
Latest Stage of DevelopmentPhase I
Standard IndicationNon-Hodgkin's lymphoma (NHL)
Indication DetailsTreat non-Hodgkin's lymphoma (NHL)
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today